000 01378 a2200409 4500
005 20250512054648.0
264 0 _c19861114
008 198611s 0 0 eng d
022 _a0042-9007
024 7 _a10.1111/j.1423-0410.1986.tb02006.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCottier, H
245 0 0 _aImmunoglobulin in chronic inflammatory diseases.
_h[electronic resource]
260 _bVox sanguinis
_c1986
300 _a39-43 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aChronic Disease
_xdrug therapy
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHLA Antigens
_ximmunology
650 0 4 _aHLA-B27 Antigen
650 0 4 _aHerpes Genitalis
_xdrug therapy
650 0 4 _aHistocompatibility Antigens Class II
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aImmunization, Passive
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aInjections, Intravenous
650 0 4 _aMajor Histocompatibility Complex
650 0 4 _aMiddle Aged
650 0 4 _aSpondylitis
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aHässig, A
773 0 _tVox sanguinis
_gvol. 51 Suppl 2
_gp. 39-43
856 4 0 _uhttps://doi.org/10.1111/j.1423-0410.1986.tb02006.x
_zAvailable from publisher's website
999 _c3495782
_d3495782